Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. HLNE
stocks logo

HLNE

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
193.88M
+15.23%
1.294
+3.52%
201.15M
+1.6%
1.358
+12.23%
214.11M
+21.68%
1.422
+8.52%
Estimates Revision
The market is revising Upward the revenue expectations for Hamilton Lane Incorporated (HLNE) for FY2026, with the revenue forecasts being adjusted by 4.91% over the past three months. During the same period, the stock price has changed by -15.63%.
Revenue Estimates for FY2026
Revise Upward
up Image
+4.91%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+12.14%
In Past 3 Month
Stock Price
Go Down
down Image
-15.63%
In Past 3 Month
Wall Street analysts forecast HLNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLNE is 162.00 USD with a low forecast of 150.00 USD and a high forecast of 181.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast HLNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLNE is 162.00 USD with a low forecast of 150.00 USD and a high forecast of 181.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 123.280
sliders
Low
150.00
Averages
162.00
High
181.00
Current: 123.280
sliders
Low
150.00
Averages
162.00
High
181.00
Goldman Sachs
Neutral -> Buy
upgrade
$165
2025-11-06
Reason
Goldman Sachs
Price Target
$165
2025-11-06
upgrade
Neutral -> Buy
Reason
Goldman Sachs upgraded Hamilton Lane to Buy from Neutral with a $165 price target. The firm says the company offers exposure to the fastest-growing segments of alternative asset management: wealth and secondaries. Hamilton Lane's recent product expansion, its Guardian relationship, and a higher institutional demand for Evergreen vehicles brings a "much more durable" growth profile going forward, the analyst tells investors in a research note. Goldman sees "compelling" valuation upside from current shared levels.
Keefe Bruyette
NULL -> Outperform
maintain
$150 -> $158
2025-11-06
Reason
Keefe Bruyette
Price Target
$150 -> $158
2025-11-06
maintain
NULL -> Outperform
Reason
Keefe Bruyette raised the firm's price target on Hamilton Lane to $158 from $150 and keeps an Outperform rating on the shares.
Morgan Stanley
Equal Weight
downgrade
$169 -> $154
2025-10-21
Reason
Morgan Stanley
Price Target
$169 -> $154
2025-10-21
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Hamilton Lane to $154 from $169 and keeps an Equal Weight rating on the shares. The firm updated its price targets for Alternative Asset Mgrs, North America under its coverage, the analyst tells investors. While credit concerns will likely dominate near-term market valuations, capital markets rebound is on track, the firm adds.
Oppenheimer
Chris Kotowski
Perform -> Outperform
upgrade
$181
2025-10-14
Reason
Oppenheimer
Chris Kotowski
Price Target
$181
2025-10-14
upgrade
Perform -> Outperform
Reason
Oppenheimer analyst Chris Kotowski upgraded Hamilton Lane to Outperform from Perform with an $181 price target.
Oppenheimer
Chris Kotowski
Perform
to
Outperform
upgrade
$181
2025-10-14
Reason
Oppenheimer
Chris Kotowski
Price Target
$181
2025-10-14
upgrade
Perform
to
Outperform
Reason
As previously reported, Oppenheimer analyst Chris Kotowski upgraded Hamilton Lane to Outperform from Perform with an $181 price target. After the November 2024 election there was a kind of euphoria about financial stocks in general, but the Alt stocks in particular, drove their average relative multiple versus the S&P, to about 165% in January 2025, the firm notes. While Oppenheimer always thinks investors should maintain some exposure to the group, the firm was selective. The group then spent most of the intervening months till September at 140% relative price-to-earnings, which Oppenheimer viewed as relatively fairly priced. Meanwhile, a sharp selloff in the group was recently sparked, and the stocks are now at a 108% relative multiple on average, and the firm believes this marks an attractive entry point.
Goldman Sachs
Sell -> Neutral
upgrade
$162
2025-09-17
Reason
Goldman Sachs
Price Target
$162
2025-09-17
upgrade
Sell -> Neutral
Reason
Goldman Sachs upgraded Hamilton Lane to Neutral from Sell with a $162 price target. Hamilton Lane has continued to improve its position in the structurally growing Wealth channel, which should remain more supportive to the firm's overall EPS growth algo, the analyst tells investors in a research note. The firm added that it expects the company to grow net asset value to roughly $31B by end-2027 on the back of stable trends in its Private Markets/Secondaries products.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Hamilton Lane Inc (HLNE.O) is 22.08, compared to its 5-year average forward P/E of 26.07. For a more detailed relative valuation and DCF analysis to assess Hamilton Lane Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
26.07
Current PE
22.08
Overvalued PE
31.17
Undervalued PE
20.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
17.12
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
20.54
Undervalued EV/EBITDA
13.69

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
7.62
Current PS
0.00
Overvalued PS
9.35
Undervalued PS
5.89
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

HLNE News & Events

Events Timeline

(ET)
2025-11-04
07:07:07
Hamilton Lane announces Q2 adjusted EPS of $1.54, surpassing consensus estimate of $1.10.
select
2025-11-03 (ET)
2025-11-03
08:04:38
Hamilton Lane and Guardian Unveil Strategic Collaboration
select
2025-09-02 (ET)
2025-09-02
19:34:30
Hamilton Lane's 528.7K Share Spot Secondary Offered at $146.58
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.5
14:00 PMBarron's
The Emerging Private-Equity Billionaires Dominating Wall Street

  • Decline of Traditional Banking: The article discusses the diminishing presence of traditional bankers as the financial industry shifts towards digital and automated services.

  • Impact of Technology: It highlights how advancements in technology and changing consumer preferences are leading to the obsolescence of old-school banking practices.

  • Cultural Shift: The piece reflects on the cultural changes within the banking sector, emphasizing a move away from personal relationships and face-to-face interactions.

  • Future of Banking: It speculates on the future landscape of banking, suggesting that the industry will continue to evolve, potentially leaving behind those who cling to outdated methods.

[object Object]
Preview
7.0
11-21WSJ
Australia Prevents U.S. Company Cosette from Acquiring Mayne Pharma for $387.2 Million

  • Government Decision: Australia has blocked a $387.2 million takeover of Mayne Pharma by U.S. company Cosette Pharmaceuticals due to national security concerns.

  • Rationale for Block: The decision was made to protect critical medical supply chains, following advice from Australia's foreign-investment watchdog.

  • Treasurer's Statement: Treasurer Jim Chalmers emphasized that no conditions could be attached to the deal to allow it to proceed.

  • Implications: This move highlights Australia's focus on safeguarding its medical infrastructure and supply chains from foreign control.

[object Object]
Preview
5.0
11-15NASDAQ.COM
Hamilton Lane Recognized as Leading Dividend Stock with Insider Purchases and 1.65% Yield (HLNE)

  • Insider Buying Insight: The article highlights the significance of insider buying, noting that company officers and directors often invest in their own stocks when they believe the shares are undervalued or the company is progressing well. An example is Hamilton Lane Incorporated - Class A (HLNE), where Co-CEO Juan Delgado-moreira purchased $1,042,831.76 worth of shares.

  • Current Stock Performance: As of the latest trading, HLNE shares were available at $128.91, slightly lower than Delgado-moreira's purchase price of $130.35. The stock has a 52-week range of $111.98 to $203.63, indicating potential for growth.

  • Dividend and Valuation Metrics: The DividendRank report emphasizes HLNE's attractive valuation and strong profitability metrics, alongside a solid quarterly dividend history, with an annualized dividend of $2.16 per share.

  • Investment Strategy: The report suggests that dividend investors should focus on profitable companies trading at attractive valuations, using the proprietary DividendRank formula to identify stocks worth further research.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Hamilton Lane Inc (HLNE) stock price today?

The current price of HLNE is 123.28 USD — it has increased 0.2 % in the last trading day.

arrow icon

What is Hamilton Lane Inc (HLNE)'s business?

Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients’ needs across a range of private markets, including private equity, private credit, real estate, infrastructure, real assets, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats, covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics.

arrow icon

What is the price predicton of HLNE Stock?

Wall Street analysts forecast HLNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLNE is 162.00 USD with a low forecast of 150.00 USD and a high forecast of 181.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Hamilton Lane Inc (HLNE)'s revenue for the last quarter?

Hamilton Lane Inc revenue for the last quarter amounts to 208.81M USD, increased 37.07 % YoY.

arrow icon

What is Hamilton Lane Inc (HLNE)'s earnings per share (EPS) for the last quarter?

Hamilton Lane Inc. EPS for the last quarter amounts to 1.69 USD, increased 23.36 % YoY.

arrow icon

What changes have occurred in the market's expectations for Hamilton Lane Inc (HLNE)'s fundamentals?

The market is revising Upward the revenue expectations for Hamilton Lane Incorporated (HLNE) for FY2026, with the revenue forecasts being adjusted by 4.91% over the past three months. During the same period, the stock price has changed by -15.63%.
arrow icon

How many employees does Hamilton Lane Inc (HLNE). have?

Hamilton Lane Inc (HLNE) has 760 emplpoyees as of December 05 2025.

arrow icon

What is Hamilton Lane Inc (HLNE) market cap?

Today HLNE has the market capitalization of 6.88B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free